361393-65-9 Usage
General Description
2,3-Dihydro-1-benzofuran-7-ylmethylamine is a chemical compound that belongs to the benzofuran class of compounds. It is a tertiary amine with a benzofuran ring structure and a methylamine group attached to the seventh position. 2,3-DIHYDRO-1-BENZOFURAN-7-YLMETHYLAMINE may have potential pharmaceutical applications as it can interact with receptors in the central nervous system. It may also have implications in the field of medicinal chemistry for the development of new drugs with therapeutic properties. Additionally, its chemical structure suggests that it may have a range of biological activities and could be a subject of interest for further research and exploration in various scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 361393-65-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,1,3,9 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 361393-65:
(8*3)+(7*6)+(6*1)+(5*3)+(4*9)+(3*3)+(2*6)+(1*5)=149
149 % 10 = 9
So 361393-65-9 is a valid CAS Registry Number.
361393-65-9Relevant articles and documents
Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H- tetrazol-5-amine P2X7 antagonists
Perez-Medrano, Arturo,Donnelly-Roberts, Diana L.,Florjancic, Alan S.,Nelson, Derek W.,Li, Tongmei,Namovic, Marian T.,Peddi, Sridhar,Faltynek, Connie R.,Jarvis, Michael F.,Carroll, William A.
, p. 3297 - 3300 (2011/07/07)
Synthesis and biological evaluation of a novel class of substituted N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine derivatives resulted in the identification of potent P2X7 antagonists. These compounds were assayed for activity at both the
THERAPEUTIC FLUOROETHYLCYANO GUANIDINES
-
, (2008/12/04)
Disclosed herein is compound having a formula as described herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE
-
, (2010/02/14)
A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R 5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.
